Dec 3, 2012 | Customer Interaction Solutions
BUYINS.NET: CELG, RGC, RFMD, QCCO, CEA, FDEF Are Seasonally Ripe To Go Down In the Next Five Weeks
Celgene Corporation discovers, develops, and commercializes innovative therapies to treat cancer and immune-inflammatory diseases in the United States, Europe, and internationally.
2 Biotech Stocks Ready To Flourish In The Wake Of Very Significant FDA News
On Friday October 12th, two companies within the biotech sector announced significant developments that had sent shares considerably higher during Friday's trading session.
Thalidomide - Comprehensive patent search - new market research report published
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.
Opinion: Why thalidomide apology is not enough
Thalidomide pills were prescribed in the late 1950s for morning sickness and as a sedative.
Thalidomide maker's apology not enough, survivor says
Thalidomide pills were prescribed in the late 1950s for morning sickness and as a sedative.